SHANDONG BOAN BIOTECH.H 1 Cash Flow-to-Debt Ratio
SHANDONG BOAN BIOTECH.H 1 cash flow-to-debt ratio. SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Cash Flow-to-Debt Ratio of 0.05x as of December 2025, meaning its operating cash flow of €64.89 Million could theoretically repay 0% of its total liabilities (€1.39 Billion) in one year. Check UJ9 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of SHANDONG BOAN BIOTECH.H 1 (2021–2025)
Cash flow-to-debt ratio of SHANDONG BOAN BIOTECH.H 1 from 2021 to 2025. Historical debt coverage capacity for SHANDONG BOAN BIOTECH.H 1 across 5 annual periods. Check SHANDONG BOAN BIOTECH.H 1 investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
SHANDONG BOAN BIOTECH.H 1 Cash Flow-to-Debt Ratio by Year (2021–2025)
SHANDONG BOAN BIOTECH.H 1 cash flow-to-debt ratio by year from 2021 to 2025. Year-by-year debt coverage analysis for SHANDONG BOAN BIOTECH.H 1. For the full cash flow conversion analysis, see UJ9 operating cash flow.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | €64.89 Million | €1.39 Billion | ▲ +147.9% |
| 2024 | -0.10x | €-117.94 Million | €1.21 Billion | ▼ -428.0% |
| 2023 | -0.02x | €-18.57 Million | €1.00 Billion | ▲ +92.8% |
| 2022 | -0.26x | €-201.84 Million | €784.18 Million | ▲ +42.0% |
| 2021 | -0.44x | €-246.28 Million | €554.92 Million | — |